CV Sciences (CVSI) Other Operating Expenses (2015 - 2017)
CV Sciences (CVSI) reported Other Operating Expenses of $2.4 million for Q4 2017, up 221.39% sequentially from $756714.0 in Q3 2015.
CV Sciences (CVSI) Other Operating Expenses (2015 - 2017) Analysis & Trends
CV Sciences (CVSI) has 2 years of Other Operating Expenses data on file, last reported at $2.4 million in Q4 2017.
- For the quarter ending Q4 2017, Other Operating Expenses changed N/A year-over-year to $2.4 million; the trailing twelve-month figure through Sep 2018 stood at $2.4 million (changed N/A YoY), and the FY2017 full-year result was $2.4 million, changed N/A from the prior year.
- Other Operating Expenses climbed to $2.4 million in Q4 2017, from $756714.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $2.4 million in Q4 2017 to a low of $756714.0 in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | CV Sciences | 4.26 Mn | 3.95 Mn | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 2.43 Mn |
| Sep 30, 2015 | 756,714.00 |